National Research CORP (NRC) — SEC Filings

Overview

National Research CORP (NRC) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 7, 2025: NATIONAL RESEARCH CORP (NRC) reported a significant decline in net income for both the three and nine months ended September 30, 2025. Net income for the three months decreased by 27.6% to $4.122 million from $5.688 million in the prior year, while the nine-month net income plummeted by 46.2% to $9.

Sentiment Summary

Across 34 filings, the sentiment breakdown is: 3 bullish, 1 bearish, 29 neutral, 1 mixed. The dominant filing sentiment for National Research CORP is neutral.

Filing Type Overview

National Research CORP (NRC) has filed 6 10-Q, 19 8-K, 2 DEF 14A, 2 10-K, 3 SC 13G/A, 2 SC 13D/A with the SEC between Jan 2024 to Nov 2025.

Filings by Year

2025 · 2024

Recent Filings (34)

• NRC Health's Q3 Net Income Plunges 27.6% Amid Rising Costs — 10-Q · Nov 7, 2025 Risk: high
  NATIONAL RESEARCH CORP (NRC) reported a significant decline in net income for both the three and nine months ended September 30, 2025. Net income for the three
• NRC Files 8-K on Financials — 8-K · Oct 27, 2025 Risk: low
  National Research Corporation (NRC) filed an 8-K on October 27, 2025, reporting on its Results of Operations and Financial Condition. The filing includes financ
• NRC Appoints New Directors, One Departs — 8-K · Aug 28, 2025 Risk: low
  National Research Corporation announced on August 25, 2025, the departure of Director Michael J. L. Collins. The company also elected two new directors, Michael
• NRC Posts Strong Q2 Growth, Net Income Up 9.9% — 10-Q · Aug 8, 2025 Risk: low
  NATIONAL RESEARCH CORP (NRC) reported a robust financial performance for the second quarter and first half of 2025. Revenue for the six months ended June 30, 20
• NRC Files 8-K on Financials — 8-K · Jul 28, 2025 Risk: low
  National Research Corporation (NRC) filed an 8-K on July 28, 2025, reporting on its results of operations and financial condition. The filing includes financial
• National Research Corp Reports Director Departure, Officer Changes — 8-K · May 12, 2025 Risk: low
  National Research Corporation announced on May 7, 2025, the departure of director Michael L. Smith. The company also reported on the election of new directors a
• NRC Q1 2025 10-Q Filing — 10-Q · May 9, 2025 Risk: low
  National Research Corporation (NRC) filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational aspects for th
• NRC Files 8-K on Financials and Operations — 8-K · Apr 28, 2025 Risk: low
  National Research Corporation (NRC) filed an 8-K on April 28, 2025, reporting on its results of operations and financial condition. The filing also included Reg
• NRC Announces Executive and Director Changes — 8-K · Apr 22, 2025 Risk: medium
  National Research Corporation (NRC) announced on April 18, 2025, changes in its executive and director roles. The filing details the departure of certain office
• NRC DEF 14A: Executive Compensation Details — DEF 14A · Apr 10, 2025 Risk: low
  National Research Corporation (NRC) filed a DEF 14A on April 10, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing
• NRC Names New CEO, CFO; Reports Director Departure — 8-K · Apr 9, 2025 Risk: medium
  National Research Corporation announced on April 3, 2025, changes in its board and officer compensation. Specifically, the company reported the departure of dir
• National Research Corp. Files 2024 10-K — 10-K · Mar 17, 2025 Risk: low
  National Research Corp. filed its 10-K for the fiscal year ending December 31, 2024, on March 17, 2025. The filing covers the company's operations and financial
• NRC Director Departs, New Director Appointed — 8-K · Mar 4, 2025 Risk: low
  National Research Corporation (NRC) announced the departure of Director, Mr. Robert L. Stover, effective February 26, 2025. The company also announced the appoi
• National Research Corp Enters Material Agreement — 8-K · Feb 10, 2025 Risk: medium
  On February 6, 2025, National Research Corporation (NRC) entered into a material definitive agreement, which also created a direct financial obligation for the
• NRC Files 8-K on Financials and Operations — 8-K · Jan 27, 2025 Risk: low
  National Research Corporation (NRC) filed an 8-K on January 27, 2025, reporting on its results of operations and financial condition. The filing also includes R
• NRC Announces Board Changes and Executive Compensation Adjustments — 8-K · Nov 14, 2024 Risk: medium
  National Research Corporation (NRC) announced on November 8, 2024, changes in its board of directors and executive compensation. Specifically, the company repor
• SC 13G/A Filing — SC 13G/A · Nov 13, 2024
• NRC Files Q3 2024 10-Q with Financial Updates — 10-Q · Nov 8, 2024 Risk: low
  National Research Corporation (NRC) filed its 10-Q for the period ending September 30, 2024. The company reported financial results for the third quarter and th
• National Research Corp Files 8-K on Financials — 8-K · Oct 25, 2024 Risk: low
  National Research Corporation (NRC) filed an 8-K on October 25, 2024, reporting on its results of operations and financial condition. The filing includes financ
• NRC Announces Officer and Director Changes — 8-K · Oct 15, 2024 Risk: medium
  National Research Corporation (NRC) announced on October 14, 2024, changes in its officer and director positions. Specifically, the company reported the departu
• NRC Q2 Earnings Show Slight Revenue and Profit Growth — 10-Q · Aug 8, 2024 Risk: low
  National Research Corporation (NRC) reported its Q2 2024 results, ending June 30, 2024. The company's revenue for the six months ended June 30, 2024, was $31,07
• NRC Files 8-K: Material Definitive Agreement Announced — 8-K · Aug 6, 2024 Risk: medium
  National Research Corporation (NRC) announced on August 5, 2024, that it entered into a Material Definitive Agreement. The filing also covers Results of Operati
• NRC Approves $20M Stock Repurchase Program — 8-K · May 13, 2024 Risk: low
  National Research Corporation (NRC) announced on May 8, 2024, that its Board of Directors approved a new stock repurchase program. The company is authorized to
• National Research Corp Files 10-Q for Q1 2024 — 10-Q · May 9, 2024 Risk: low
  NATIONAL RESEARCH CORP (NRC) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Revenue for the three months ended March 31, 2024, was $31,078,202, an
• NRC Appoints Michael L. DeBord as New CEO — 8-K · May 7, 2024 Risk: medium
  National Research Corporation (NRC) announced on May 7, 2024, that its Board of Directors has appointed Michael L. DeBord as the new Chief Executive Officer, ef
• National Research Corp Files Definitive Proxy Statement — DEF 14A · Apr 11, 2024 Risk:
  NATIONAL RESEARCH CORP (NRC) filed a Proxy Statement (DEF 14A) with the SEC on April 11, 2024. The filing is a Definitive Proxy Statement (DEF 14A) for National
• SC 13G/A Filing — SC 13G/A · Mar 8, 2024
• Common Property Trust Amends National Research Corp Filing — SC 13D/A · Mar 5, 2024 Risk: medium
  On March 5, 2024, Common Property Trust, managed by Thomas Richardson, filed an amendment to its Schedule 13D. This filing indicates a change in beneficial owne
• National Research Corp. Files 2023 Annual Report (10-K) — 10-K · Feb 27, 2024 Risk: low
  NATIONAL RESEARCH CORP (NRC) filed a Annual Report (10-K) with the SEC on February 27, 2024. Total revenue for the fiscal year ended December 31, 2023, was $31,
• NRC 8-K: Financials & Officer Changes Reported Feb 8, 2024 — 8-K · Feb 13, 2024 Risk: medium
  National Research Corporation filed an 8-K on February 13, 2024, reporting on events that occurred on February 8, 2024. The filing covers 'Results of Operations
• Kayne Anderson Rudnick Amends NRC Stake, Signals Continued Passive Hold — SC 13G/A · Feb 13, 2024 Risk: low
  Kayne Anderson Rudnick Investment Management, LLC, a California-based investment firm, filed an Amendment No. 8 to its SC 13G filing on February 13, 2024, indic
• NRC Files 8-K on Officer/Director Changes, Compensation — 8-K · Jan 17, 2024
  National Research Corporation filed an 8-K on January 17, 2024, reporting an event that occurred on January 16, 2024. This filing indicates a current report pur
• Amandla MK Trust Amends NRC Stake, Patrick Beans Advises — SC 13D/A · Jan 4, 2024
  The Amandla MK Trust, advised by Patrick E. Beans, filed an Amendment No. 8 to their Schedule 13D on January 2, 2024, regarding their ownership in National Rese
• NRC Files 8-K on Officer/Director Changes, Compensation — 8-K · Jan 2, 2024
  National Research Corporation (NRC) filed an 8-K on January 2, 2024, reporting an event that occurred on December 28, 2023. This filing is a standard disclosure

Risk Profile

Risk Assessment: Of NRC's 28 recent filings, 1 were flagged as high-risk, 9 as medium-risk, and 18 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from National Research CORP's most recent 10-Q filing (Nov 7, 2025):

• Revenue: $102.196M
• Net Income: $9.802M
• Debt-to-Equity: 8.48
• Cash Position: $2.219M
• Operating Margin: 17.54%
• Total Assets: $135.719M
• Total Debt: $114.439M

Key Executives

• Michael J. L. Collins
• Mark J. L. Collins
• Michael L. Smith
• Christopher J. Gentry
• Timothy J. Johnson
• Robert L. Stover
• Jennifer L. Johnson
• John D. Danner
• Michael J. O'Malley
• Michael L. DeBord
• Thomas Richardson

Industry Context

The market research and consulting industry, where National Research Corp operates, is characterized by intense competition and a need for continuous innovation to adapt to evolving client demands and data analytics technologies. Companies in this sector often rely on recurring revenue models and strong client relationships. Recent trends indicate a growing demand for data-driven insights and predictive analytics, putting pressure on firms to invest in technology and talent.

Top Tags

financial-reporting (5) · corporate-governance (4) · director-departure (4) · financials (4) · 8-k (3) · board-composition (3) · 10-Q (3) · executive-compensation (3) · compensation (3) · amendment (3)

Key Numbers

• Net Income (Q3 2025): $4.122M — Down 27.6% from $5.688M in Q3 2024
• Net Income (9M 2025): $9.802M — Down 46.2% from $18.223M in 9M 2024
• Revenue (Q3 2025): $34.608M — Down 3.4% from $35.819M in Q3 2024
• Revenue (9M 2025): $102.196M — Down 3.7% from $106.154M in 9M 2024
• Interest Expense (Q3 2025): $1.461M — Up 106.9% from $706K in Q3 2024
• Interest Expense (9M 2025): $3.393M — Up 81.8% from $1.866M in 9M 2024
• Total Liabilities (Sep 30, 2025): $121.405M — Up from $101.255M at Dec 31, 2024
• Total Shareholders' Equity (Sep 30, 2025): $14.314M — Down 54.3% from $31.284M at Dec 31, 2024
• Cash and Cash Equivalents (Sep 30, 2025): $2.219M — Down from $4.233M at Dec 31, 2024
• Notes Payable (Sep 30, 2025): $76.025M — Up from $57.895M at Dec 31, 2024
• Revenue (H1 2025): $36.5M — Increased by 6.7% from $34.2M in H1 2024
• Net Income (H1 2025): $7.8M — Increased by 9.9% from $7.1M in H1 2024
• Revenue Growth: 6.7% — Year-over-year growth for the first half of 2025
• Net Income Growth: 9.9% — Year-over-year growth for the first half of 2025
• Total Assets (June 30, 2025): $125.3M — Increased from $123.8M at December 31, 2024

Forward-Looking Statements

• {"claim":"Kayne Anderson Rudnick will maintain a passive investment strategy in National Research Corp.","entity":"Kayne Anderson Rudnick Investment Management, LLC","targetDate":"next 12 months","confidence":"high"}

Frequently Asked Questions